CERC - Spark Newswire

1 minute read

News

Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.

August 26, 7:35 AM

Name change underscores the Company's transition to developing innovative targeted therapies in immunology, immuno-oncology, and rare genetic diseases Robust pipeline of six product candidates advancing in

AVTX

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

August 6, 4:31 PM

Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value of their outstanding shares is at $29.3 million.

AQB

1 minute read

Clinicaltrials.gov Site Shows Cerecor-Sponsored Study ‘A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations’ Not Yet Recruiting

By Bill Haddad

August 6, 8:55 AM

https://clinicaltrials.gov/ct2/show/NCT04994002

CERC

1 minute read

6 Stocks Moving In Monday’s After-Hours Session

By Tyree Gorges

July 26, 5:03 PM

Gainers Cerecor (NASDAQ: CERC) shares are trading higher after the company announced initial Phase 1b results for CERC-002 in moderate to severe Crohn's Disease patients.

AGRX

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

July 26, 4:32 PM

Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) stock increased by 25.64% to $3.92 during Monday's after-market session. The company's market cap stands at $27.8 million.

ADTX

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

July 9, 5:20 PM

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded at a volume of 379 shares come close, making up 0.45% of its average volume over the last 100 days. The company's market cap stands at $87.4 million.

ASLN

1 minute read

Cerecor Says Entered Into Controlled Equity Offering Sales Agreement; Says Pursuant To Sales Agreement Co. May Issue, Sell Common Stock Having Offering Price Of Up To $50M

By Michael Horton

July 2, 4:26 PM

-Reuters

CERC

4 minute read

The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus

By Shanthi Rexaline

June 27, 12:55 PM

Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment.

AFMD

2 minute read

Cerecor Licenses Immune Checkpoint Program From Sanford Burnham Prebys Further Expanding Pipeline Of Immunology And Immuno-oncology Targets

By Bill Haddad

June 23, 7:32 AM

Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunology, immuno-oncology and rare genetic disorders, today announced that

CERC

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 4, 2021

By Benzinga Insights

June 4, 10:03 AM

ADS

Feed Symbols: CERC